On June 11, 2025, the Food and Drug Administration approved taletrectinib (Ibtrozi, Nuvation Bio Inc.), a kinase inhibitor, for adults with locally advanced or metastatic ROS1-positive non-small cell lung cancer (NSCLC).
Similar Posts
Joint US FDA – Health Canada ICH Public Meeting – 02/22/2024
Joint US FDA – Health Canada ICH Public MeetingFrank Steven Eder, MD. Binghamton, NY. EIR issued 11/23/2020
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 11/23/2020
Short Title (70 char) Frank Steven Eder, MD. Binghamton NY. EIR issued 11/23/2020
FEI Number 3006983127
Firm Name Frank Steven Eder, MD
Record Type EIR
State FL
Establishment Type Clinical InvestigatBSO, LLC. Golden, CO. 483 issued 06/27/2025
Task Description Request Please post to the OII FOIA Electronic Reading Room
Record Date 06/27/2025
Short Title (70 char) BSO, LLC. Golden, CO. 483 issued 06/27/2025
FEI Number 3030548360
Firm Name BSO, LLC
Record Type 483
State CO
Establishment Type Outsourcing FacilityFace Rock Creamery LLC Recalls 6oz. Vampire Slayer Garlic Cheddar Because of Possible Health Risk
November 14, 2025, Face Rock Creamery LLC of Bandon, OR is voluntarily recalling 16/6oz. units of Vampire Slayer Garlic Cheddar with a use-by date of 11/04/26 because it has the potential to be contaminated with Listeria monocytogenes, an organism which can cause serious and sometimes fatal infectioKonrad Rejdak, MD, PhD – 671405 – 05/01/2025
Bioresearch Monitoring Program/IRBDr. Reddy’s Laboratories, LTD, Biologics – 09/12/2025
Dr. Reddy’s Laboratories, LTD, Biologics – 09/12/2025. Country: India. Record Type: 483